Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News DarioHealth Corp DRIO

DarioHealth Corp. is a global digital therapeutics (DTx) company. The Company operates at the intersection of life sciences, behavioral science, and software technology to deliver seamlessly integrated and highly engaging digital therapeutic interventions. Its platform and suite of solutions delivers personalized and dynamic interventions driven by data analytics and one-on-one coaching for... see more

Recent & Breaking News (NDAQ:DRIO)

Dario Announces Strategic Partnership with Amwell to Expand Access to its Cardiometabolic Digital Therapeutic Solution

PR Newswire March 22, 2023

Dario Publishes New Research Demonstrating Digital Personalization of Pain Management with Adapted Machine Learning

PR Newswire March 14, 2023

DarioHealth Reports Fourth Quarter and Record Revenue in Full-Year 2022 Financial and Operating Results

PR Newswire March 9, 2023

DarioHealth to Report Fourth Quarter 2022 Results on Thursday, March 9th

PR Newswire March 2, 2023

What Do Sanofi And Dexcom See In DarioHealth That The Market Is Missing?

TheNewsWire February 28, 2023

New Research from Dario Demonstrates Improved Clinical Outcomes in Two New Studies at the Advanced Technologies and Treatments for Diabetes 2023 Conference

PR Newswire February 27, 2023

DarioHealth to Participate in the Cowen 43rd Annual Healthcare Conference

PR Newswire February 24, 2023

Dario Appoints Industry Veteran Jon Kaplan to Board

PR Newswire February 23, 2023

Dario Partners to Integrate Dexcom CGM Data

PR Newswire February 8, 2023

DarioHealth Announces Preliminary Fourth Quarter and Full Year 2022 Operating Results

PR Newswire February 6, 2023

Dario Adds New Senior Vice President of Growth to Expanding Sales Team

PR Newswire January 24, 2023

Dario Publishes New Research in Peer Reviewed Journal Demonstrating Improved Outcomes by Race and Ethnicity

PR Newswire January 9, 2023

Dario Achieves Goal of 100 Business-to-Business Contracts in 2022

PR Newswire January 3, 2023

DarioHealth Corp. (NASDAQ: DRIO) Prominently Positioned for Digital Therapeutics Consolidation

TheNewsWire December 21, 2022

New Research Published in Peer Reviewed Journal Demonstrating Dario's Musculoskeletal Solution Reduces Back Pain

PR Newswire December 19, 2022

Two New Employers Join Dario Through Benefits Brokerage Partner

PR Newswire December 1, 2022

Dario to Participate in Craig-Hallum and BTIG Digital Health

PR Newswire November 16, 2022

DarioHealth Reports Third Quarter 2022 Financial and Operating Results

PR Newswire November 14, 2022

DarioHealth to Report Third Quarter 2022 Results on Monday, November 14th

PR Newswire November 9, 2022

Dario Announces Two Employer Contracts for Full Suite of Digital Health Solutions

PR Newswire October 20, 2022